LOW PLASMA REDUCED HALOPERIDOL HALOPERIDOL RATIOS IN CHINESE PATIENTS

被引:0
作者
CHANG, WH
CHEN, TY
LEE, CF
HU, WH
YEH, EK
机构
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:1406 / 1408
页数:3
相关论文
共 50 条
[41]   CYP2D6 genotype and plasma levels of haloperidol and reduced haloperidol in Japanese [J].
Kondo, T ;
Suzuki, A ;
Mihara, K ;
Yasui, N ;
Kaneko, S .
MOLECULAR MEDICINE: NOVEL FINDINGS OF GENE DIAGNOSIS, REGULATION OF GENE EXPRESSION, AND GENE THERAPY, 1999, 1172 :81-86
[42]   CORRELATION OF CLINICAL-RESPONSE (PANSS) AND PLASMA-LEVELS OF HALOPERIDOL AND REDUCED HALOPERIDOL IN SCHIZOPHRENIA [J].
LEROUX, JM ;
ELIA, E ;
JACQUET, M ;
POMMERY, J ;
LEVRON, JC ;
BOUHOURS, P ;
ERB, F ;
SECHTER, D .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1994, 18 (02) :347-353
[43]   SIMULTANEOUS DETERMINATION OF PLASMA HALOPERIDOL AND ITS METABOLITE REDUCED HALOPERIDOL BY LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION - PLASMA-LEVELS IN SCHIZOPHRENIC-PATIENTS TREATED WITH ORAL OR INTRAMUSCULAR DEPOT HALOPERIDOL [J].
ARAVAGIRI, M ;
MARDER, SR ;
VANPUTTEN, T ;
MARSHALL, BD .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1994, 656 (02) :373-381
[44]   PLASMA RBC HALOPERIDOL RATIOS AND IMPROVEMENT IN ACUTE PSYCHOTIC SYMPTOMS [J].
NEBORSKY, RJ ;
JANOWSKY, DS ;
PEREL, JM ;
MUNSON, E ;
DEPRY, D .
JOURNAL OF CLINICAL PSYCHIATRY, 1984, 45 (01) :10-13
[45]   EFFECTS OF HALOPERIDOL AND REDUCED HALOPERIDOL ON BINDING TO SIGMA-SITES [J].
KLEIN, M ;
COOPER, TB ;
MUSACCHIO, JM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 254 (03) :239-248
[46]   THE MEASUREMENT OF HALOPERIDOL AND REDUCED HALOPERIDOL IN HAIR AS AN INDEX OF DOSAGE HISTORY [J].
MATSUNO, H ;
UEMATSU, T ;
NAKASHIMA, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 29 (02) :187-194
[47]   INTERCONVERSION BETWEEN HALOPERIDOL AND REDUCED HALOPERIDOL IN HEALTHY-VOLUNTEERS [J].
CHAKRABORTY, BS ;
HUBBARD, JW ;
HAWES, EM ;
MCKAY, G ;
COOPER, JK ;
GURNSEY, T ;
KORCHINSKI, ED ;
MIDHA, KK .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 37 (01) :45-48
[48]   REDUCED HALOPERIDOL - A FACTOR IN DETERMINING THE THERAPEUTIC BENEFIT OF HALOPERIDOL TREATMENT [J].
CHANG, WH .
PSYCHOPHARMACOLOGY, 1992, 106 (03) :289-296
[49]   PHARMACODYNAMICS AND PHARMACOKINETICS OF HALOPERIDOL AND REDUCED HALOPERIDOL IN GUINEA-PIGS [J].
CHANG, WH ;
JAW, SS ;
WU, HS ;
TSAY, L ;
YEH, EK .
PSYCHOPHARMACOLOGY, 1988, 96 (03) :285-288
[50]   PLASMA-LEVEL DETERMINATION OF HALOPERIDOL AND REDUCED HALOPERIDOL IN PATIENTS WITH TREATMENT REFRACTORY SCHIZOPHRENIA BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY [J].
REED, KL ;
COLLINS, EJ ;
HOGAN, TP ;
AWAD, AG .
SCHIZOPHRENIA RESEARCH, 1991, 4 (03) :293-293